Advertisement
Screener

Savara Inc (SVRA) Current State and Local Tax Expense (Benefit)

2.8 / 5 stars · 68/120 Roast Me

Savara Inc Current State and Local Tax Expense (Benefit)

Savara Inc (SVRA) reported Current State and Local Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-03-13

  • Savara Inc current state and local tax expense (benefit) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Savara Inc current state and local tax expense (benefit) for fiscal 2024 was $9.00K.
  • Savara Inc current state and local tax expense (benefit) for fiscal 2023 was $0.00.
  • Savara Inc current state and local tax expense (benefit) for fiscal 2022 was $0.00.
Period endCurrent State and Local Tax Expense (Benefit) 12 month
2025-12-31$0.00
10-K · filed 2026-03-13
2024-12-31$9.00K
10-K · filed 2026-03-13
2023-12-31$0.00
10-K · filed 2026-03-13
2022-12-31$0.00
10-K · filed 2024-03-07
2021-12-31$0.00
10-K · filed 2023-03-30
2020-12-31$0.00
10-K · filed 2022-03-30
2019-12-31$0.00
10-K · filed 2021-03-10
2018-12-31$0.00
10-K · filed 2020-03-12
2017-12-31$0.00
10-K · filed 2019-03-13
2016-12-31$0.00
10-K · filed 2018-03-14
2015-12-31$0.00
10-K · filed 2018-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B